CAMTEK LTD (CAMT)

IL0010952641 - Common Stock

75.51  +0.34 (+0.45%)

After market: 75.51 0 (0%)

Fundamental Rating

6

Taking everything into account, CAMT scores 6 out of 10 in our fundamental rating. CAMT was compared to 108 industry peers in the Semiconductors & Semiconductor Equipment industry. CAMT has an excellent profitability rating, but there are some minor concerns on its financial health. CAMT is not overvalued while it is showing excellent growth. This is an interesting combination. These ratings would make CAMT suitable for growth investing!



7

1. Profitability

1.1 Basic Checks

CAMT had positive earnings in the past year.
CAMT had positive earnings in each of the past 5 years.
Each year in the past 5 years CAMT had a positive operating cash flow.

1.2 Ratios

CAMT has a better Return On Assets (12.01%) than 78.70% of its industry peers.
CAMT's Return On Equity of 20.11% is amongst the best of the industry. CAMT outperforms 84.26% of its industry peers.
With an excellent Return On Invested Capital value of 11.11%, CAMT belongs to the best of the industry, outperforming 82.41% of the companies in the same industry.
CAMT had an Average Return On Invested Capital over the past 3 years of 11.38%. This is in line with the industry average of 11.05%.
Industry RankSector Rank
ROA 12.01%
ROE 20.11%
ROIC 11.11%
ROA(3y)10.71%
ROA(5y)10.52%
ROE(3y)19.29%
ROE(5y)16.71%
ROIC(3y)11.38%
ROIC(5y)11.46%

1.3 Margins

CAMT has a better Profit Margin (25.93%) than 85.19% of its industry peers.
In the last couple of years the Profit Margin of CAMT has grown nicely.
The Operating Margin of CAMT (23.00%) is better than 79.63% of its industry peers.
In the last couple of years the Operating Margin of CAMT has grown nicely.
The Gross Margin of CAMT (47.36%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of CAMT has remained more or less at the same level.
Industry RankSector Rank
OM 23%
PM (TTM) 25.93%
GM 47.36%
OM growth 3Y13.43%
OM growth 5Y5.43%
PM growth 3Y21.29%
PM growth 5Y10.39%
GM growth 3Y-0.12%
GM growth 5Y-1.05%

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CAMT is destroying value.
The number of shares outstanding for CAMT has been increased compared to 1 year ago.
The number of shares outstanding for CAMT has been increased compared to 5 years ago.
The debt/assets ratio for CAMT has been reduced compared to a year ago.

2.2 Solvency

CAMT has an Altman-Z score of 8.35. This indicates that CAMT is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CAMT (8.35) is better than 75.00% of its industry peers.
A Debt/Equity ratio of 0.42 indicates that CAMT is not too dependend on debt financing.
CAMT has a Debt to Equity ratio of 0.42. This is in the lower half of the industry: CAMT underperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF N/A
Altman-Z 8.35
ROIC/WACC0.77
WACC14.48%

2.3 Liquidity

CAMT has a Current Ratio of 5.21. This indicates that CAMT is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 5.21, CAMT is doing good in the industry, outperforming 78.70% of the companies in the same industry.
A Quick Ratio of 4.29 indicates that CAMT has no problem at all paying its short term obligations.
The Quick ratio of CAMT (4.29) is better than 78.70% of its industry peers.
Industry RankSector Rank
Current Ratio 5.21
Quick Ratio 4.29

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 38.83% over the past year.
Measured over the past years, CAMT shows a very strong growth in Earnings Per Share. The EPS has been growing by 27.44% on average per year.
The Revenue has decreased by -1.72% in the past year.
CAMT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 20.69% yearly.
EPS 1Y (TTM)38.83%
EPS 3Y44.97%
EPS 5Y27.44%
EPS Q2Q%47.06%
Revenue 1Y (TTM)-1.72%
Revenue growth 3Y26.48%
Revenue growth 5Y20.69%
Sales Q2Q%39.6%

3.2 Future

CAMT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 25.22% yearly.
The Revenue is expected to grow by 21.35% on average over the next years. This is a very strong growth
EPS Next Y41.69%
EPS Next 2Y28.36%
EPS Next 3Y24.11%
EPS Next 5Y25.22%
Revenue Next Year33.83%
Revenue Next 2Y24.7%
Revenue Next 3Y19.95%
Revenue Next 5Y21.35%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 28.93, which means the current valuation is very expensive for CAMT.
Compared to the rest of the industry, the Price/Earnings ratio of CAMT indicates a somewhat cheap valuation: CAMT is cheaper than 68.52% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 28.96. CAMT is around the same levels.
Based on the Price/Forward Earnings ratio of 23.50, the valuation of CAMT can be described as rather expensive.
Based on the Price/Forward Earnings ratio, CAMT is valued a bit cheaper than 66.67% of the companies in the same industry.
CAMT is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 23.82, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 28.93
Fwd PE 23.5

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CAMT is valued a bit cheaper than the industry average as 60.19% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 32.7

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of CAMT may justify a higher PE ratio.
CAMT's earnings are expected to grow with 24.11% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.69
PEG (5Y)1.05
EPS Next 2Y28.36%
EPS Next 3Y24.11%

3

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 1.77%, CAMT has a reasonable but not impressive dividend return.
The stock price of CAMT dropped by -22.93% in the last 3 months. With lower prices the dividend yield is higher, but it may be a sign investors do not trust the long term dividend.
CAMT's Dividend Yield is rather good when compared to the industry average which is at 2.37. CAMT pays more dividend than 87.96% of the companies in the same industry.
Compared to the average S&P500 Dividend Yield of 2.23, CAMT is paying slightly less dividend.
Industry RankSector Rank
Dividend Yield 1.77%

5.2 History

CAMT has paid a dividend for less than 5 years, so there is no long track record yet.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

DPN/A
EPS Next 2Y28.36%
EPS Next 3Y24.11%

CAMTEK LTD

NASDAQ:CAMT (11/21/2024, 5:20:01 PM)

After market: 75.51 0 (0%)

75.51

+0.34 (+0.45%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.43B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 1.77%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 28.93
Fwd PE 23.5
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)0.69
PEG (5Y)1.05
Profitability
Industry RankSector Rank
ROA 12.01%
ROE 20.11%
ROCE
ROIC
ROICexc
ROICexgc
OM 23%
PM (TTM) 25.93%
GM 47.36%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.46
Health
Industry RankSector Rank
Debt/Equity 0.42
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 5.21
Quick Ratio 4.29
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)38.83%
EPS 3Y44.97%
EPS 5Y
EPS Q2Q%
EPS Next Y41.69%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-1.72%
Revenue growth 3Y26.48%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y